TESARO Inc.

TESARO Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
54.91 M
Public Float
16.79 M
TESARO Inc.
Stock Exchange NASDAQ Stock Market
EPS
$9.84
Market Cap
$1.93 B
Shares Outstanding
54.91 M
Public Float
38.27 M

Profile

Address
1000 Winter Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.tesarobio.com
Updated 09/14/2018
TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr.

Financials

View All

Leon O. Moulder
Chief Executive Officer & Director
Mary Lynne Hedley
President, Chief Operating Officer & Director